Provided by Tiger Trade Technology Pte. Ltd.

Cytosorbents

0.6566
-0.0924-12.34%
Volume:260.49K
Turnover:183.27K
Market Cap:41.24M
PE:-3.85
High:0.7300
Open:0.7000
Low:0.6552
Close:0.7490
52wk High:1.61
52wk Low:0.6000
Shares:62.80M
Float Shares:54.98M
Volume Ratio:3.37
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1705
EPS(LYR):-0.3806
ROE:-93.26%
ROA:-19.01%
PB:4.57
PE(LYR):-1.73

Loading ...

CytoSorbents Corporation Leadership Joins D. Boral Capital for Virtual Fireside Chat

Reuters
·
Yesterday

CytoSorbents CEO Phillip P. Chan Reports Acquisition of Common Shares

Reuters
·
Nov 21

CytoSorbents Q3 Revenue USD 9.485 Million

Reuters
·
Nov 20

CytoSorbents Corporation to Present at Jefferies Global Healthcare Conference

Reuters
·
Nov 18

CytoSorbents Corporation reports Q3 2025 revenue of $9.5 million

Reuters
·
Nov 15

Cytosorbents Corp’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 15

Cytosorbents Is Maintained at Neutral by HC Wainwright & Co.

Dow Jones
·
Nov 14

CytoSorbents Reports Third Quarter 2025 Revenue of $9.5 Million

Reuters
·
Nov 14

Blood purification firm CytoSorbents Q3 revenue misses estimates

Reuters
·
Nov 14

CytoSorbents Q3 Revenue USD 9.485 Million

Reuters
·
Nov 14

CytoSorbents Reports 10% Revenue Growth and Improved Gross Margins in Q3 2025

Reuters
·
Nov 14

Cytosorbents Corp: Reduced Its Workforce by Approximately 10%

THOMSON REUTERS
·
Nov 14

Cytosorbents Corp: Expects to Reach Operating Cash Flow Break-Even in Q1 of 2026

THOMSON REUTERS
·
Nov 14

Cytosorbents Q3 Product Gross Margin 70%

THOMSON REUTERS
·
Nov 14

Cytosorbents Q3 Adjusted EPS USD -0.04

THOMSON REUTERS
·
Nov 14

Cytosorbents Corp: Announced Implementation of a Strategic Workforce and Cost Reduction Plan

THOMSON REUTERS
·
Nov 14

Market Cool On Cytosorbents Corporation's (NASDAQ:CTSO) Revenues Pushing Shares 31% Lower

Simply Wall St.
·
Nov 13

CytoSorbents Corporation to Participate in Jefferies Global Healthcare Conference in London

Reuters
·
Nov 11

CytoSorbents Corporation to Announce Third Quarter 2025 Financial Results

Reuters
·
Oct 30

Cytosorbents Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
Oct 04